Related Experiment Video
Updated: Dec 21, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Nanotherapeutic systems for delivering cancer vaccines: recent advances
Sarwar Beg1, Khalid S Alharbi2, Nabil K Alruwaili3
1Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India.
Abstract:
With an increase in the global burden of cancer-related deaths, the quest for developing new therapeutic solutions has taken momentum. In this regard, the idea of using cancer vaccines came to existence approximately 30 years ago, where gene therapy interventions have shown significant improvement in the therapeutic outcomes against several types of cancers. Cancer vaccines usually encounter a number of challenges with limited targeting ability to the tumors. Nanocarriers have been studied as a technological innovation for tumor targeting of gene therapeutics. This article provides a critical insight into the recent progress made in nanotherapeutic strategies for genetic vaccine delivery for treatment against various types of cancers. Moreover, the article intends to provide a summary of the research work being done on this topic.
Insights
Advancements in nanocarrier technology offer improved tumor targeting for cancer vaccines, enhancing gene therapy effectiveness. This research reviews nanotherapeutic strategies for genetic vaccine delivery in cancer treatment.
Area of Science:
- Oncology
- Biotechnology
- Nanomedicine
Background:
- Rising global cancer deaths necessitate novel therapeutic strategies.
- Cancer vaccines, particularly gene therapy, have shown promise but face challenges in tumor targeting.
- Nanocarriers represent a key innovation for enhancing gene therapeutic delivery.
Purpose of the Study:
- To critically review recent progress in nanotherapeutic strategies for cancer vaccine delivery.
- To summarize current research on nanocarrier-based genetic vaccines for cancer treatment.
Main Methods:
- Review of recent scientific literature on nanocarriers and cancer gene therapy.
- Analysis of nanotherapeutic approaches for targeted delivery of genetic vaccines.
Main Results:
- Nanocarriers demonstrate significant potential in improving tumor-specific delivery of gene therapeutics.
- Various nanocarrier systems are being explored for enhanced efficacy of cancer vaccines.
Conclusions:
- Nanotherapeutic strategies are crucial for overcoming limitations in current cancer vaccine technology.
- Continued research in nanocarrier-based genetic vaccines holds promise for improved cancer treatment outcomes.
More Related Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics